Wolverine Trading’s Fulgent Genetics FLGT Stock Holding History

Wolverine Trading’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$250K	Buy	+11,200	New	+$231K	﹤0.01%	4645
2024 Q2	–	Sell	-16,600	Closed	-$360K	–	4693
2024 Q1	$360K	Buy	+16,600	New	+$412K	﹤0.01%	3169
2023 Q2	–	Sell	-24,000	Closed	-$713K	–	4449
2023 Q1	$713K	Sell	24,000 -37,800	-61%	-$1.22M	﹤0.01%	2197
2022 Q4	$1.84M	Buy	61,800 +2,800	+5%	+$100K	﹤0.01%	1447
2022 Q3	$2.29M	Buy	+59,000	New	+$2.96M	﹤0.01%	1321
2022 Q2	–	Sell	-30,100	Closed	-$1.89M	–	4889
2022 Q1	$1.89M	Sell	30,100 -9,900	-25%	-$652K	﹤0.01%	1824
2021 Q4	$4.07M	Sell	40,000 -28,200	-41%	-$2.48M	﹤0.01%	1289
2021 Q3	$6.13M	Sell	68,200 -9,100	-12%	-$827K	0.01%	1151
2021 Q2	$7.4M	Sell	77,300 -400	-0.5%	-$31.9K	0.01%	852
2021 Q1	$7.17M	Buy	77,700 +48,600	+167%	+$5.02M	0.01%	886
2020 Q4	$1.48M	Buy	+29,100	New	+$1.22M	﹤0.01%	1991

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Wolverine Trading's FLGT Position: Q3 2025 in Review

Wolverine Trading sold out of Fulgent Genetics (FLGT) in Q3 2025, closing a stake of 13,513 shares — an estimated $278K sold.

Wolverine Trading first reported a position in FLGT in Q4 2020 and held it in 5 quarters. The position peaked at $1.78M in Q1 2021. 163 funds tracked by Wall St. Rank hold FLGT as of Q3 2025.

Wolverine Trading reported no remaining Fulgent Genetics position as of Q3 2025 after selling out during the quarter.
Wolverine Trading sold 13,513 Fulgent Genetics shares in Q3 2025, an estimated $278K.
Wolverine Trading first reported a position in Fulgent Genetics in Q4 2020 and held it in 5 quarters.
Wolverine Trading's Fulgent Genetics position peaked at $1.78M in Q1 2021.
163 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.